Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 5/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.38 |
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 3/20 | 0.36 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.36 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.36 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.36 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.36 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.36 |
| ▸ | MYC | P01106 | 1/20 | 0.34 |
| ▸ | MMP3 | P08254 | 1/20 | 0.33 |
| ▸ | KAT6A | Q92794 | 1/20 | 0.33 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20618987 | 1.00 | PDK2 (0.52) | PDK2OPRD1BACE1KCNH2MAOB | |
| SCHEMBL20619346 | 0.96 | PDK2 (0.49) | PDK2OPRD1BACE1KCNH2MAOB | |
| SCHEMBL20222614 | 0.93 | PDK2 (0.54) | PDK2OPRD1BACE1KCNH2MAOB | |
| SCHEMBL20619779 | 0.92 | PDK2 (0.44) | PDK2OPRD1BACE1KCNH2MAOB | |
| SCHEMBL20222787 | 0.92 | PDK2 (0.55) | PDK2OPRD1BACE1KCNH2MAOB | |
| SCHEMBL19298647 | 0.92 | PDK2 (0.49) | PDK2OPRD1BACE1KCNH2MAOB | |
| SCHEMBL20619231 | 0.92 | PDK2 (0.49) | PDK2OPRD1BACE1KCNH2MAOB | |
| SCHEMBL29808802 | 0.92 | PDK2 (0.54) | PDK2OPRD1MAOBPGRGABRA1 | |
| SCHEMBL20619113 | 0.91 | PDK2 (0.53) | PDK2MAOBPGRGABRA1GABRG2 | |
| SCHEMBL22484422 | 0.91 | PDK2 (0.47) | PDK2OPRD1BACE1KCNH2PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230024114-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEM, LTD. (KR) | 2023-01-26 | — | — | US | disclosed |
| US-20220376178-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEM, LTD. (KR) | 2022-11-24 | — | — | US | disclosed |
| US-11152576-B2 | Organic light emitting device | LG CHEM, LTD. (KR) | 2021-10-19 | — | — | US | disclosed |
| US-20210288264-A1 | Heterocyclic Compound And Organic Light Emitting Element Comprising Same | LG CHEM, LTD. (KR) | 2021-09-16 | — | — | US | disclosed |
| US-11094889-B2 | Heterocyclic compound and organic light emitting element comprising same | LG CHEM, LTD. | 2021-08-17 | — | — | US | disclosed |
| US-20210013422-A1 | ORGANIC LIGHT EMITTING DEVICE | LG CHEM, LTD. (KR) | 2021-01-14 | — | — | US | disclosed |
| EP-3595025-B1 | ORGANIC LIGHT EMITTING ELEMENT | LG CHEMICAL LTD (KR) | 2020-12-30 | — | — | EP | disclosed |
| US-20200365814-A1 | ORGANIC LIGHT-EMITTING DEVICE | LG CHEM, LTD. (KR) | 2020-11-19 | — | — | US | disclosed |
| US-20200035930-A1 | ORGANIC LIGHT EMITTING ELEMENT | LG CHEM, LTD. (KR) | 2020-01-30 | — | — | US | disclosed |
| WO-2019004782-A1 | ORGANIC LIGHT EMITTING ELEMENT | 주식회사 엘지화학 | 2019-01-03 | — | — | WO | disclosed |
| WO-2019004787-A1 | ORGANIC LIGHT EMITTING ELEMENT | 주식회사 엘지화학 | 2019-01-03 | — | — | WO | disclosed |
| WO-2017146466-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME | 주식회사 엘지화학 | 2017-08-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210288264-A1 | Heterocyclic Compound And Organic Light Emitting Element Comprising Same | CRY1, CRY2, PER2 | PDK2 2812/4885OPRD1 826/4885BACE1 616/4885 |
| US-11094889-B2 | Heterocyclic compound and organic light emitting element comprising same | CRY1, CRY2, PER2 | PDK2 2812/4885OPRD1 826/4885BACE1 616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.